Valuation workshop - A real world perspective

"Market cap  and value of your equity is about the size of a CEO’s ego, it’s the price per share with which you pay for your kid’s education" said an US-based Biotech CEO.

Although a funny quote, it has a deep meaning on how to create value as a Biotech/MedTech company.

Mostly suited to CEOs, CSOs, CFOs, scientists of biotech/medtech companies, our full day workshop is designed to provide a real-world valuation perspective you can use for either raising money from investors, or in discussion with strategic partners. Having valued more than 50 assets since 2010, we are adept at providing training to the CEOs/CSOs of life sciences companies, who can leverage this knowledge in creating value for their shareholders and themselves.

Topics

• How Investors/VCs think and how you should pitch and adapt to them
• How to develop strong fundamentals when valuing an asset. What are the different ways of valuing a biotech asset? How NOT to value an asset
• How to structure licensing deals, co-development deals etc.

Price
Early Bird rate till 26th May
Non members: 1,799 EUR
Swiss Biotech Association member: 1,299 EUR
Startups that haven't raised any money: 1,200 EUR

Please reach out with the contact possibility below for the discounts related to Swiss Biotech Association members or startups. For others, you can directly book your seat by registering.